Pew Experts RSS Feed. http://www.pewtrusts.org/news_room.aspx A statement by Allan Coukell, director of medical programs at Pew Health Group, about the enactment of the Food and Drug Administration Safety and Innovation Act. Mon, 09 Jul 2012 15:00:00 GMT http://www.pewtrusts.org/news_room_detail.aspx?id=85899403834&WT.rss_ev=f&WT.rss_f=Expert Feed : Allan Coukell&WT.rss_a=Pew Applauds Enactment of User Fee Legislation, Urges Its Swift Implementation&WT.z_contenttype=PressRelease Allan Coukell, deputy director of the Medical Safety Portfolio of the Pew Health Group, talks about drug safety on C-SPAN. Tue, 26 Jun 2012 09:45:00 GMT http://www.pewtrusts.org/news_room_detail.aspx?id=85899401346&WT.rss_ev=f&WT.rss_f=Expert Feed : Allan Coukell&WT.rss_a=Pew's Allan Coukell Discusses FDA Reform Act of 2012&WT.z_contenttype=PewInTheMedia The U.S. House of Representatives Wednesday passed the Food and Drug Administration Safety and Innovation Act (S. 3187), a bill to support the FDA’s drug and device reviews. “We commend the House for passing the bipartisan Food and Drug Administration Safety and Innovation Act," said Allan Coukell, director of medical programs at the Pew Health Group. Thu, 21 Jun 2012 10:15:00 GMT http://www.pewtrusts.org/news_room_detail.aspx?id=85899400333&WT.rss_ev=f&WT.rss_f=Expert Feed : Allan Coukell&WT.rss_a=Pew Applauds U.S. House Passage of FDA User Fee Legislation&WT.z_contenttype=PressRelease The U.S. House of Representatives passed bipartisan legislation to ensure that the U.S. Food and Drug Administration (FDA) has the funds it needs to approve products that improve health and protect consumers from unnecessary risks. Wed, 30 May 2012 19:00:00 GMT http://www.pewtrusts.org/news_room_detail.aspx?id=85899395229&WT.rss_ev=f&WT.rss_f=Expert Feed : Allan Coukell&WT.rss_a=Pew Applauds Passage of Bipartisan User Fee Legislation by U.S. House of Representatives&WT.z_contenttype=PressRelease Allan Coukell, Pew Health Group medical director, is quoted in an Associated Press article about Senate passage of FDA user fee legislation that also aims to improve the safety and quality of imported drugs. Fri, 25 May 2012 09:05:00 GMT http://www.pewtrusts.org/news_room_detail.aspx?id=85899391476&WT.rss_ev=f&WT.rss_f=Expert Feed : Allan Coukell&WT.rss_a=Senate Bill Aims to Increase Drug Import Safety&WT.z_contenttype=NewsArticle An article in The Wall Street Journal on counterfeit drugs quotes Allan Coukell, medical director at Pew Health Group, over concerns about doctors purchasing cheaper foreign drugs. Mon, 23 Apr 2012 13:00:00 GMT http://www.pewtrusts.org/news_room_detail.aspx?id=85899382294&WT.rss_ev=f&WT.rss_f=Expert Feed : Allan Coukell&WT.rss_a=FDA Alerts Doctors on Fakes&WT.z_contenttype=NewsArticle <p>Allan Coukell, Director of Medical Programs testifies before the Senate Committee on Health, Education, Labor and Pensions on the importance of the user fee agreement legislation to patients and public health.</p> Thu, 29 Mar 2012 10:00:00 GMT http://www.pewtrusts.org/news_room_detail.aspx?id=85899378976&WT.rss_ev=f&WT.rss_f=Expert Feed : Allan Coukell&WT.rss_a=Testimony of Allan Coukell before the Senate Committee on Health, Education, Labor and Pensions&WT.z_contenttype=Speech An editorial in the Minneapolis Star Tribune about counterfeit drugs quotes Allan Coukell, medical director at Pew Health Group, on the need for a strong, uniform national standards and systems to track authentic drugs. Wed, 28 Mar 2012 14:05:00 GMT http://www.pewtrusts.org/news_room_detail.aspx?id=85899378854&WT.rss_ev=f&WT.rss_f=Expert Feed : Allan Coukell&WT.rss_a=Editorial: Crack Down on Counterfeit Drugs&WT.z_contenttype=NewsArticle <p>Allan Coukell, Director of Medical Programs, and Sharon Ladin, Director of the Antibiotics and Innovation Project, testify before the House Committee on Energy and Commerce, Subcommittee on Health on stimulating the development of new antibiotics urgently needed to fight serious and life-threatening bacterial infections</p> Thu, 08 Mar 2012 14:00:00 GMT http://www.pewtrusts.org/news_room_detail.aspx?id=85899375544&WT.rss_ev=f&WT.rss_f=Expert Feed : Allan Coukell&WT.rss_a=Testimony of Allan Coukell and Sharon Ladin before the House Committee on Energy and Commerce, Subcommittee on Health&WT.z_contenttype=Speech Terms and Conditions Page http://www.pewtrusts.org/terms_and_conditions.aspx